302 related articles for article (PubMed ID: 17107340)
1. Postulated role of interdomain interaction between regions 1 and 2 within type 1 ryanodine receptor in the pathogenesis of porcine malignant hyperthermia.
Murayama T; Oba T; Hara H; Wakebe K; Ikemoto N; Ogawa Y
Biochem J; 2007 Mar; 402(2):349-57. PubMed ID: 17107340
[TBL] [Abstract][Full Text] [Related]
2. Postulated role of interdomain interactions within the type 1 ryanodine receptor in the low gain of Ca2+-induced Ca2+ release activity of mammalian skeletal muscle sarcoplasmic reticulum.
Murayama T; Oba T; Kobayashi S; Ikemoto N; Ogawa Y
Am J Physiol Cell Physiol; 2005 Jun; 288(6):C1222-30. PubMed ID: 15677376
[TBL] [Abstract][Full Text] [Related]
3. Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel (ryanodine receptor isoform 1).
Du GG; Oyamada H; Khanna VK; MacLennan DH
Biochem J; 2001 Nov; 360(Pt 1):97-105. PubMed ID: 11695996
[TBL] [Abstract][Full Text] [Related]
4. Stimulation and inhibition of [3H]ryanodine binding to sarcoplasmic reticulum from malignant hyperthermia susceptible pigs.
Mickelson JR; Litterer LA; Jacobson BA; Louis CF
Arch Biochem Biophys; 1990 Apr; 278(1):251-7. PubMed ID: 2321964
[TBL] [Abstract][Full Text] [Related]
5. Antibody probe study of Ca2+ channel regulation by interdomain interaction within the ryanodine receptor.
Kobayashi S; Yamamoto T; Parness J; Ikemoto N
Biochem J; 2004 Jun; 380(Pt 2):561-9. PubMed ID: 15027895
[TBL] [Abstract][Full Text] [Related]
6. Malignant hyperthermia mutation sites in the Leu2442-Pro2477 (DP4) region of RyR1 (ryanodine receptor 1) are clustered in a structurally and functionally definable area.
Bannister ML; Hamada T; Murayama T; Harvey PJ; Casarotto MG; Dulhunty AF; Ikemoto N
Biochem J; 2007 Jan; 401(1):333-9. PubMed ID: 16958617
[TBL] [Abstract][Full Text] [Related]
7. Divergent effects of the malignant hyperthermia-susceptible Arg(615)-->Cys mutation on the Ca(2+) and Mg(2+) dependence of the RyR1.
Balog EM; Fruen BR; Shomer NH; Louis CF
Biophys J; 2001 Oct; 81(4):2050-8. PubMed ID: 11566777
[TBL] [Abstract][Full Text] [Related]
8. Calmodulin sensitivity of the sarcoplasmic reticulum ryanodine receptor from normal and malignant-hyperthermia-susceptible muscle.
O'Driscoll S; McCarthy TV; Eichinger HM; Erhardt W; Lehmann-Horn F; Herrmann-Frank A
Biochem J; 1996 Oct; 319 ( Pt 2)(Pt 2):421-6. PubMed ID: 8912676
[TBL] [Abstract][Full Text] [Related]
9. Selectively suppressed Ca2+-induced Ca2+ release activity of alpha-ryanodine receptor (alpha-RyR) in frog skeletal muscle sarcoplasmic reticulum: potential distinct modes in Ca2+ release between alpha- and beta-RyR.
Murayama T; Ogawa Y
J Biol Chem; 2001 Jan; 276(4):2953-60. PubMed ID: 11054412
[TBL] [Abstract][Full Text] [Related]
10. Reduced inhibitory effect of Mg2+ on ryanodine receptor-Ca2+ release channels in malignant hyperthermia.
Laver DR; Owen VJ; Junankar PR; Taske NL; Dulhunty AF; Lamb GD
Biophys J; 1997 Oct; 73(4):1913-24. PubMed ID: 9336187
[TBL] [Abstract][Full Text] [Related]
11. RyR1 exhibits lower gain of CICR activity than RyR3 in the SR: evidence for selective stabilization of RyR1 channel.
Murayama T; Ogawa Y
Am J Physiol Cell Physiol; 2004 Jul; 287(1):C36-45. PubMed ID: 14985235
[TBL] [Abstract][Full Text] [Related]
12. 4-Chloro-m-cresol: a specific tool to distinguish between malignant hyperthermia-susceptible and normal muscle.
Herrmann-Frank A; Richter M; Lehmann-Horn F
Biochem Pharmacol; 1996 Jul; 52(1):149-55. PubMed ID: 8678899
[TBL] [Abstract][Full Text] [Related]
13. Divergent Activity Profiles of Type 1 Ryanodine Receptor Channels Carrying Malignant Hyperthermia and Central Core Disease Mutations in the Amino-Terminal Region.
Murayama T; Kurebayashi N; Yamazawa T; Oyamada H; Suzuki J; Kanemaru K; Oguchi K; Iino M; Sakurai T
PLoS One; 2015; 10(6):e0130606. PubMed ID: 26115329
[TBL] [Abstract][Full Text] [Related]
14. Effects of a domain peptide of the ryanodine receptor on Ca2+ release in skinned skeletal muscle fibers.
Lamb GD; Posterino GS; Yamamoto T; Ikemoto N
Am J Physiol Cell Physiol; 2001 Jul; 281(1):C207-14. PubMed ID: 11401843
[TBL] [Abstract][Full Text] [Related]
15. Genotype-Phenotype Correlations of Malignant Hyperthermia and Central Core Disease Mutations in the Central Region of the RYR1 Channel.
Murayama T; Kurebayashi N; Ogawa H; Yamazawa T; Oyamada H; Suzuki J; Kanemaru K; Oguchi K; Iino M; Sakurai T
Hum Mutat; 2016 Nov; 37(11):1231-1241. PubMed ID: 27586648
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Chlorantraniliprole and Flubendiamide Activity Toward Wild-Type and Malignant Hyperthermia-Susceptible Ryanodine Receptors and Heat Stress Intolerance.
Truong KM; Pessah IN
Toxicol Sci; 2019 Feb; 167(2):509-523. PubMed ID: 30329129
[TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity of the ryanodine receptor to halothane-induced oligomerization in malignant hyperthermia-susceptible human skeletal muscle.
Glover L; Heffron JJ; Ohlendieck K
J Appl Physiol (1985); 2004 Jan; 96(1):11-8. PubMed ID: 12959958
[TBL] [Abstract][Full Text] [Related]
18. Interaction of the Lys(3614)-Asn(3643) calmodulin-binding domain with the Cys(4114)-Asn(4142) region of the type 1 ryanodine receptor is involved in the mechanism of Ca2+/agonist-induced channel activation.
Gangopadhyay JP; Ikemoto N
Biochem J; 2008 Apr; 411(2):415-23. PubMed ID: 18171325
[TBL] [Abstract][Full Text] [Related]
19. The point mutation Arg615-->Cys in the Ca2+ release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia.
Otsu K; Nishida K; Kimura Y; Kuzuya T; Hori M; Kamada T; Tada M
J Biol Chem; 1994 Apr; 269(13):9413-5. PubMed ID: 7511586
[TBL] [Abstract][Full Text] [Related]
20. Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia.
Mickelson JR; Gallant EM; Litterer LA; Johnson KM; Rempel WE; Louis CF
J Biol Chem; 1988 Jul; 263(19):9310-5. PubMed ID: 3379071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
